Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by SUSAN DENFIELD and JACK PRICE.
SUSAN DENFIELD
Connection Strength
3.729
JACK PRICE
  1. Clinical Characteristics and Treatment of Cardiomyopathies in Children. Curr Cardiol Rev. 2016; 12(2):85-98.
    View in: PubMed
    Score: 0.563
  2. Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure. J Card Fail. 2006 Mar; 12(2):139-43.
    View in: PubMed
    Score: 0.284
  3. Symptom complex is associated with transplant coronary artery disease and sudden death/resuscitated sudden death in pediatric heart transplant recipients. J Heart Lung Transplant. 2005 Nov; 24(11):1798-803.
    View in: PubMed
    Score: 0.271
  4. Relation of Low Chloride Concentration to Diuretic Efficiency and Transplant-Free Survival in Children Hospitalized With Heart Failure. Am J Cardiol. 2022 12 01; 184:72-79.
    View in: PubMed
    Score: 0.224
  5. Poor efficacy of oral iron replacement therapy in pediatric patients with heart failure. Cardiol Young. 2022 Aug; 32(8):1302-1309.
    View in: PubMed
    Score: 0.210
  6. Pediatric heart-liver transplant outcomes in the United States: A 25-year National Cohort Study. Pediatr Transplant. 2021 Nov; 25(7):e14066.
    View in: PubMed
    Score: 0.205
  7. Diuretic Responsiveness and Its Prognostic Significance in Children With Heart Failure. J Card Fail. 2019 Dec; 25(12):941-947.
    View in: PubMed
    Score: 0.177
  8. Missed Diagnosis of New-Onset Systolic Heart Failure at First Presentation in Children with No Known Heart Disease. J Pediatr. 2019 05; 208:258-264.e3.
    View in: PubMed
    Score: 0.174
  9. Incidence, Severity, and Association With Adverse Outcome of Hyponatremia in Children Hospitalized With Heart Failure. Am J Cardiol. 2016 Oct 01; 118(7):1006-10.
    View in: PubMed
    Score: 0.146
  10. Postoperative complications associated with perioperative sirolimus prior to pediatric cardiac retransplantation. J Pediatr Pharmacol Ther. 2014 Jan; 19(1):30-4.
    View in: PubMed
    Score: 0.122
  11. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol. 2009 Jul 14; 54(3):250-4.
    View in: PubMed
    Score: 0.090
  12. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome? Pediatr Crit Care Med. 2008 May; 9(3):279-84.
    View in: PubMed
    Score: 0.083
  13. Effect of body mass index on outcome in pediatric heart transplant patients. J Heart Lung Transplant. 2007 Jul; 26(7):718-23.
    View in: PubMed
    Score: 0.078
  14. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation. 2006 Sep 05; 114(10):1063-9.
    View in: PubMed
    Score: 0.074
  15. Leukocyte suppression is associated with improved clinical outcomes in children's status after orthotopic heart transplantation. J Heart Lung Transplant. 2006 Feb; 25(2):195-9.
    View in: PubMed
    Score: 0.070
  16. Arginine vasopressin levels are elevated and correlate with functional status in infants and children with congestive heart failure. Circulation. 2004 Jun 01; 109(21):2550-3.
    View in: PubMed
    Score: 0.063
  17. Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study. Pediatr Crit Care Med. 2022 10 01; 23(10):e465-e475.
    View in: PubMed
    Score: 0.055
  18. Ventricular assist device support for children with chemotherapy-induced cardiomyopathy and advanced heart failure: Perspectives gained from a single-center experience. Pediatr Transplant. 2022 08; 26(5):e14286.
    View in: PubMed
    Score: 0.054
  19. Does Cardiac Catheterization Facilitate Hemodynamic Optimization of Pediatric Patients on Continuous-Flow Ventricular Assist Devices? ASAIO J. 2022 04 01; 68(4):584-591.
    View in: PubMed
    Score: 0.054
  20. Trends in Body Mass Index and Association With Outcomes in Pediatric Patients on Continuous Flow Ventricular Assist Device Support. ASAIO J. 2022 09 01; 68(9):1182-1190.
    View in: PubMed
    Score: 0.053
  21. Simultaneous pediatric heart-kidney transplant outcomes in the US: A-25 year National Cohort Study. Pediatr Transplant. 2022 Feb; 26(1):e14149.
    View in: PubMed
    Score: 0.052
  22. "Compassionate" Cases of the Jarvik 2015 Ventricular Assist Device. ASAIO J. 2021 09 01; 67(9):1036-1043.
    View in: PubMed
    Score: 0.052
  23. Hospital outcomes for pediatric heart transplant recipients undergoing tracheostomy: A multi-institutional analysis. Pediatr Transplant. 2021 May; 25(3):e13904.
    View in: PubMed
    Score: 0.049
  24. A Recipient Risk Prediction Tool for Short-term Mortality After Pediatric Heart Transplantation. Transplantation. 2019 11; 103(11):2434-2439.
    View in: PubMed
    Score: 0.046
  25. Iron Deficiency Is Associated with Adverse Outcomes in Pediatric Heart Failure. J Pediatr. 2020 01; 216:58-66.e1.
    View in: PubMed
    Score: 0.046
  26. Improved 6 Minute Walk Distance and Brain-Type Natriuretic Peptide After Continuous-Flow Ventricular Assist Device Placement in Children. ASAIO J. 2019 Sep/Oct; 65(7):725-730.
    View in: PubMed
    Score: 0.045
  27. Prevalence of Anemia and Iron Deficiency in Pediatric Patients on Ventricular Assist Devices. ASAIO J. 2018 Nov/Dec; 64(6):795-801.
    View in: PubMed
    Score: 0.043
  28. Ventricular Assist Device Support: Single Pediatric Institution Experience Over Two Decades. Ann Thorac Surg. 2019 03; 107(3):829-836.
    View in: PubMed
    Score: 0.043
  29. Hospital Charges for Pediatric Heart Failure-Related Hospitalizations from 2000 to 2009. Pediatr Cardiol. 2016 Mar; 37(3):512-8.
    View in: PubMed
    Score: 0.035
  30. Novel Use of Tolvaptan in a Pediatric Patient With Congestive Heart Failure Due to Duchenne Muscular Dystrophy and Congenital Adrenal Hyperplasia. J Pediatr Pharmacol Ther. 2015 Sep-Oct; 20(5):393-6.
    View in: PubMed
    Score: 0.034
  31. Arrhythmias in children with ventricular assist devices. Cardiol Young. 2015 Feb; 25(2):255-60.
    View in: PubMed
    Score: 0.033
  32. Response to letter regarding article, "mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center". Circulation. 2014 Jan 21; 129(3):e300.
    View in: PubMed
    Score: 0.031
  33. Infectious complications and outcomes in children supported with left ventricular assist devices. J Heart Lung Transplant. 2013 May; 32(5):518-24.
    View in: PubMed
    Score: 0.029
  34. Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis. J Card Fail. 2011 Jun; 17(6):487-94.
    View in: PubMed
    Score: 0.025
  35. Assessment of the Cylex ImmuKnow cell function assay in pediatric heart transplant patients. J Heart Lung Transplant. 2009 Jan; 28(1):26-31.
    View in: PubMed
    Score: 0.022
  36. B-type natriuretic peptide is a sensitive screening test for acute rejection in pediatric heart transplant patients. J Heart Lung Transplant. 2008 Jun; 27(6):649-54.
    View in: PubMed
    Score: 0.021
  37. Use of mechanical circulatory support in pediatric patients with acute cardiac graft rejection. ASAIO J. 2007 Nov-Dec; 53(6):701-5.
    View in: PubMed
    Score: 0.020
  38. Over two decades of pediatric heart transplantation: how has survival changed? J Thorac Cardiovasc Surg. 2007 Mar; 133(3):632-9.
    View in: PubMed
    Score: 0.019
  39. Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children. Circulation. 2005 Sep 13; 112(11):1612-7.
    View in: PubMed
    Score: 0.017
  40. Radio-frequency catheter ablation of accessory pathway mediated tachycardia in a child after orthotopic heart transplantation. J Heart Lung Transplant. 2005 Sep; 24(9):1444.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.